Avalo Therapeutics
Avalo Therapeutics, formerly Cerecor & Aevi Genomic, is a clinical stage biotechnology company focused on the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network.

Year Established: 2011
Stock Ticker: AVTX
Exchange: NASDAQ